ALPS Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-40,244
| Closed | -$443K | – | 1000 |
|
|
2023
Q1 | $443K | Sell |
40,244
-1,099
| -3% | -$12.1K | ﹤0.01% | 601 |
|
|
2022
Q4 | $612K | Buy |
41,343
+8,530
| +26% | +$126K | 0.01% | 555 |
|
|
2022
Q3 | $627K | Buy |
32,813
+2,314
| +8% | +$44.2K | 0.01% | 555 |
|
|
2022
Q2 | $650K | Sell |
30,499
-21,284
| -41% | -$454K | 0.01% | 539 |
|
|
2022
Q1 | $997K | Sell |
51,783
-6,420
| -11% | -$124K | 0.01% | 314 |
|
|
2021
Q4 | $1.21M | Sell |
58,203
-3,375
| -5% | -$70K | 0.01% | 337 |
|
|
2021
Q3 | $1.47M | Sell |
61,578
-4,546
| -7% | -$109K | 0.01% | 350 |
|
|
2021
Q2 | $1.81M | Sell |
66,124
-24,490
| -27% | -$669K | 0.02% | 339 |
|
|
2021
Q1 | $2.62M | Buy |
90,614
+21,589
| +31% | +$624K | 0.03% | 234 |
|
|
2020
Q4 | $1.94M | Buy |
69,025
+20,331
| +42% | +$572K | 0.02% | 288 |
|
|
2020
Q3 | $1.43M | Sell |
48,694
-3,359
| -6% | -$98.4K | 0.02% | 284 |
|
|
2020
Q2 | $1.57M | Buy |
+52,053
| New | +$1.57M | 0.02% | 260 |
|